Jean Fajadet

Summary

Publications

  1. doi Current management of left main coronary artery disease
    Jean Fajadet
    Clinique Pasteur, Toulouse, France
    Eur Heart J 33:36-50b. 2012
  2. doi Early and long-term results of unprotected left main coronary artery stenosis with paclitaxel-eluting stents: the FRIEND (French multicentre RegIstry for stenting of uNprotecteD LMCA stenosis) registry
    Didier Carrie
    Cardiology B Department, CHU Rangueil, Toulouse, France
    EuroIntervention 7:680-8. 2011
  3. doi Stent implantation in aorto-ostial lesions: long-term follow-up and predictors of outcome
    Andre Luz
    Clinique Pasteur, Toulouse, France
    EuroIntervention 7:1069-76. 2012
  4. doi Adverse impact of bleeding and transfusion on the outcome post-transcatheter aortic valve implantation: insights from the Pooled-RotterdAm-Milano-Toulouse In Collaboration Plus (PRAGMATIC Plus) initiative
    Didier Tchetche
    Clinique Pasteur, Toulouse, France
    Am Heart J 164:402-9. 2012
  5. ncbi Long-term follow-up of percutaneous coronary intervention of unprotected left main lesions with drug eluting stents: predictors of clinical outcome
    Andrea Pavei
    Clinique Pasteur, Toulouse, France
    EuroIntervention 4:457-63. 2009
  6. ncbi Catheter-induced left main dissection: a treatment dilemma
    Niall T Mulvihill
    Unite de Cardiologie Interventionelle, Clinique Pasteur, Toulouse, France
    Catheter Cardiovasc Interv 59:214-6. 2003
  7. doi Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study
    Jean Fajadet
    Clinique Pasteur, Toulouse, France
    EuroIntervention 6:562-7. 2010
  8. ncbi Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial
    Jean Fajadet
    Clinique Pasteur, Toulouse, France
    Circulation 114:798-806. 2006
  9. ncbi Percutaneous treatment of coronary subclavian steal syndrome
    Niall T Mulvihill
    Unite de Cardiologie Interventionelle, Clinique Pasteur, Toulouse, France
    J Invasive Cardiol 15:390-2. 2003
  10. ncbi Five-year survival in patients with ST-segment-elevation myocardial infarction according to modalities of reperfusion therapy: the French Registry on Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) 2005 Cohort
    Nicolas Danchin
    Assistance Publique Hopitaux de Paris, Hopital Europeen Georges Pompidou, Paris, France N D, E P INSERM U 970, Paris, France N D, E P Université Paris Descartes, Paris, France N D, E P Assistance Publique Hôpitaux de Paris, Hopital Bichat, Paris, France P G S INSERM U 698, Paris, France P G S Université Paris Diderot, Paris, France P G S Centre Hospitalier Régional Universitaire de Lille, Lille, France P G Hôpital Jean Minjoz, Besancon, France F S Université de Franche Comté, Besancon, France F S Centre Hospitalier d Annecy, Annecy, France L B Hôpital du Bocage, Dijon, France Y C Université de Bourgogne, Dijon, France Y C Clinique Pasteur, Toulouse, France J Fajadet Centre Hospitalier Régional de Metz Thionville, Metz, France K K Hôpital du Haut Levêque, Pessac, France P C Université Bordeaux Segalen, Bordeaux, France P C Hôpital Rangueil, Toulouse, Department of Embryology and Teratology
    Circulation 129:1629-36. 2014

Detail Information

Publications16

  1. doi Current management of left main coronary artery disease
    Jean Fajadet
    Clinique Pasteur, Toulouse, France
    Eur Heart J 33:36-50b. 2012
    ..Further randomized trials must be conducted to precise the indications of both techniques of revascularization in the treatment of LM disease...
  2. doi Early and long-term results of unprotected left main coronary artery stenosis with paclitaxel-eluting stents: the FRIEND (French multicentre RegIstry for stenting of uNprotecteD LMCA stenosis) registry
    Didier Carrie
    Cardiology B Department, CHU Rangueil, Toulouse, France
    EuroIntervention 7:680-8. 2011
    ..Percutaneous coronary intervention (PCI) is an increasingly utilised method of revascularisation in patients with ULMCA...
  3. doi Stent implantation in aorto-ostial lesions: long-term follow-up and predictors of outcome
    Andre Luz
    Clinique Pasteur, Toulouse, France
    EuroIntervention 7:1069-76. 2012
    ..To compare the outcomes of drug-eluting (DES) vs. bare-metal (BMS) stents for stenting of native aorto-ostial lesions (AOL) and to identify predictors of major adverse cardio and cerebrovascular events (MACCE)...
  4. doi Adverse impact of bleeding and transfusion on the outcome post-transcatheter aortic valve implantation: insights from the Pooled-RotterdAm-Milano-Toulouse In Collaboration Plus (PRAGMATIC Plus) initiative
    Didier Tchetche
    Clinique Pasteur, Toulouse, France
    Am Heart J 164:402-9. 2012
    ..Little is known about the impact of bleeding and red blood cells transfusion (RBC) on the outcome post transcatheter aortic valve implantation (TAVI)...
  5. ncbi Long-term follow-up of percutaneous coronary intervention of unprotected left main lesions with drug eluting stents: predictors of clinical outcome
    Andrea Pavei
    Clinique Pasteur, Toulouse, France
    EuroIntervention 4:457-63. 2009
    ..To evaluate the long-term follow-up of drug-eluting stents (DES) in the treatment of unprotected left main coronary artery (ULMCA)...
  6. ncbi Catheter-induced left main dissection: a treatment dilemma
    Niall T Mulvihill
    Unite de Cardiologie Interventionelle, Clinique Pasteur, Toulouse, France
    Catheter Cardiovasc Interv 59:214-6. 2003
    ..However, there are potential life threatening complications which can occasionally occur. We describe one such complication and detail the management and clinical outcome...
  7. doi Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study
    Jean Fajadet
    Clinique Pasteur, Toulouse, France
    EuroIntervention 6:562-7. 2010
    ....
  8. ncbi Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial
    Jean Fajadet
    Clinique Pasteur, Toulouse, France
    Circulation 114:798-806. 2006
    ..The use of the Endeavor stent might reduce restenosis and stent thrombosis at 9 months...
  9. ncbi Percutaneous treatment of coronary subclavian steal syndrome
    Niall T Mulvihill
    Unite de Cardiologie Interventionelle, Clinique Pasteur, Toulouse, France
    J Invasive Cardiol 15:390-2. 2003
    ..This syndrome can be successfully treated percutaneously with excellent immediate and long-term results...
  10. ncbi Five-year survival in patients with ST-segment-elevation myocardial infarction according to modalities of reperfusion therapy: the French Registry on Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) 2005 Cohort
    Nicolas Danchin
    Assistance Publique Hopitaux de Paris, Hopital Europeen Georges Pompidou, Paris, France N D, E P INSERM U 970, Paris, France N D, E P Université Paris Descartes, Paris, France N D, E P Assistance Publique Hôpitaux de Paris, Hopital Bichat, Paris, France P G S INSERM U 698, Paris, France P G S Université Paris Diderot, Paris, France P G S Centre Hospitalier Régional Universitaire de Lille, Lille, France P G Hôpital Jean Minjoz, Besancon, France F S Université de Franche Comté, Besancon, France F S Centre Hospitalier d Annecy, Annecy, France L B Hôpital du Bocage, Dijon, France Y C Université de Bourgogne, Dijon, France Y C Clinique Pasteur, Toulouse, France J Fajadet Centre Hospitalier Régional de Metz Thionville, Metz, France K K Hôpital du Haut Levêque, Pessac, France P C Université Bordeaux Segalen, Bordeaux, France P C Hôpital Rangueil, Toulouse, Department of Embryology and Teratology
    Circulation 129:1629-36. 2014
    ..Although primary percutaneous coronary intervention (pPCI) is the preferred reperfusion method for ST-segment-elevation myocardial infarction, it remains difficult to implement in many areas, and fibrinolytic therapy is still widely used...
  11. ncbi Twelve month clinical and angiographic outcome after stenting of unprotected left main coronary artery stenosis with paclitaxel-eluting stents--results of the multicentre FRIEND registry
    Didier Carrie
    Cardiology Department, Rangueil Hospital, Toulouse, France
    EuroIntervention 4:449-56. 2009
    ..The overall event rate for PCI of ULMCA disease remains higher than in on-label use making additional outcome data and risk-stratification tools for the ULMCA population desirable...
  12. doi Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve® Accutrak™ system
    Didier Tchetche
    Groupe CardioVasculaire Interventionnel, Clinique Pasteur, Toulouse, France
    EuroIntervention 8:556-62. 2012
    ..The aims of this paper were to describe the potential impact of the Accutrak™ catheter on the accuracy of positioning a 26 or 29 mm CoreValve® across the aortic annulus and its impact on the need for a pacemaker...
  13. ncbi Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards Sapien and Medtronic CoreValve bioprostheses in a mixed population
    Didier Tchetche
    Clinique Pasteur, Toulouse, France
    EuroIntervention 5:659-65. 2010
    ..We report 30-day data from a mixed population of patients treated with either Medtronic CoreValve (MCV) or Edwards SAPIEN (ES) valves...
  14. ncbi Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial
    Jean Fajadet
    Clinique Pasteur, 45, Avenue du Lombez, 31300 Toulouse, France
    Circulation 111:1040-4. 2005
    ..This analysis examined whether these beneficial effects persist over the longer term...
  15. ncbi First report of transradial renal denervation with the dedicated radiofrequency Iberis™ catheter
    Benjamin Honton
    Cardiovascular Unit of the Clinique Pasteur, Toulouse, France
    EuroIntervention 9:1385-8. 2014
    ..Radiofrequency energy is delivered at the tip of the catheter. The system was CE approved in March 2013. ..
  16. ncbi Impact of restenosis and disease progression on clinical outcome after multivessel stenting in diabetic patients
    Mohamed Loutfi
    Unite de Cardiologie Interventionelle, Clinique Pasteur, Toulouse, France
    Catheter Cardiovasc Interv 58:451-4. 2003
    ..Consequently, even if drug-eluting stent technology can eliminate restenosis, disease progression will continue to impact the clinical outcome of diabetic patients after PCI...